Flashcards in Exam #02 - Alzheimer's Disease Deck (22):
Which of the following statements is false?
A. Early onset AD progresses over a 5-15 yr period
B. AD is a result of polyproteinopathy
C. Behavioral changes increase with AD progression
D. AD results in progressively severe brain atrophy and loss of brain mass
E. Prevalence of AD increases exponentially with age
Early onset AD (age 40-64) progresses RAPIDLY leading to death in only 2-3 YEARS while LATE onset AD progresses over a 5-15 year period
What (2) proteins implicated in AD pathology form potentially pathogenic conformations and accumulate in the brain?
True or False - early onset AD is hereditary and its onset may be caused by mutations in (3) genes?
What is the strongest genetic risk factor for late onset AD?
Epsilon-4 allele of Apolipoprotein E (which is involved in the transport of cholesterol)
Which of the following statements is correct?
A. risk of developing AD decreases with atherosclerosis, peripheral vascular disease, and type II DM
B. Epsilon allele of APOE (apolipoprotein E) impairs amyloid clearance and increases aggregation and deposition
C. Amyloid plaques are twisted fibers, composed of tau protein
D. Neurofibrillary Tangles (NFTs) are dense deposits of protein around nerve cells
(B) is the only correct statement:
Epsilon allele of APOE (apolipoprotein E) impairs amyloid clearance and increases aggregation and deposition
A. Risk INCREASES with atherosclerosis, peripheral vascular disease, and type II DM
C. Amyloid plaques form when dense deposits of beta amyloid protein (A-beta) and cellular material accumulate outside and around nerve cells
D. NFTs are twisted fibers, composed of tau protein build up inside the nerve cell
What (2) regions of the brain involved in memory and learning are most affected in early stages of AD?
True of False - there is a correlation between progressive loss of cholinergic neurons and symptom severity?
True or False - a patient with mild AD would require assistance with daily activities?
False - a patient with moderate AD would require assistance with daily activities
All the following are symptoms of severe AD except?
A. Motor disturbance
E. Unstable gait
(B) wandering is NOT a symptom of severe AD. In severe AD the patient is bedridden. Wandering is a symptom of moderate AD.
Dysphagia is difficulty in swallowing
Incontinence is the inability to control urination and defecation
True or False - beta-amyloids are short polypeptides that accumulate and form plaque?
True - Amyloid Precursor Protein (APP) is cleaved by Beta-secretase forming beta amyloids
Under normal conditions Tau proteins stabilize microtubules. What causes the tau proteins to tangle into neurofibrillary tangles?
Hyperphosphorylation and truncation of tau causes tangle
True or False - under normal circumstances, amyloid precursor protein (APP) is cleaved by secretases to from soluble proteins?
However, beta-secretase cleaves a little higher than other secretases producing insoluble proteins (A-beta proteins) that accumulate and form a plaque
Which PET ligand used in diagnostic/biomarker of AD progression binds to amyloid plaque but not to regions of the brain devoid of plaque?
Name the (5) drugs used to treat AD?
1. Donepezil (Aricept ®)
2. Galantimine (Razadyne ®)
3. Memantine (Nemanda ®)
4. Rivastigmine (Excelon ®)
5. Tacrine (Cognex ®)
Which of the following drugs used to treat AD is NOT an AChE inhibitor?
(B) Memantine is an NMDA ANTAGONIST, not an AChE inhibitor
Which drug used to treat AD comes as a transdermal patch?
Rivastigmine (Excelon ®)
All of the following drugs would be appropriate to treat mild to moderate AD except?
(B) Memantine is an NMDA antagonist used to treat moderate - severe AD
All the AChE inhibitors are used to treat mild to moderate AD
What (4) AE are associated with AChE inhibitors for Tx of AD?
less AE with titration dosing
True or False - anticholinergic drugs decrease the effectiveness of AChE inhibitors?
True - they block ACh receptors
Anticholinergics that would decrease AChE inhibitor effectiveness: benadryl, oxybutynin, imipramine (TCA)
What type of AD is Nemanda used to treat?
moderate to severe AD
What (4) AE are associated with Memantine for Tx of AD?
Memantine (Nemanda ®) is an NMDA antagonist